Laboratory:Akiruno
- TOP
- gene-related test
- genetic tests for malignant tumor (solid tumor)
- AmoyDx lung cancer multi-panel 7-gene IVD (FF)
Laboratory:Akiruno
○AmoyDx lung cancer multi-panel 7-gene IVD (FF)
CODE:00Q32 9
-
TEST NAME
SPECIMEN
REQUIREMENT
(mL) CONTAINER CAP COLOR STORE
TEMPERATURE
(STABILITY) TURNAROUND
TIME (DAY) METHODOLOGY REFERENCE RANGE
(UNIT) -
AmoyDx lung cancer multi-panel 7-gene IVD (FF)
tissue
100mg
ARR
4-7 PCR (real-time PCR), RT-PCR (real-time PCR)
COMMENT
The purpose of this study is to analyze BRAF V600E mutations, EGFR gene mutation, ALK fusion gene, ROS1 fusion gene, MET gene exon 14 skipping mutation, KRAS G12C gene mutation, and RET fusion gene in genomic DNA and RNA extracted from cancer tissues to determine the indications for the drugs listed in the attached table for patients with non-small cell lung cancer.
The available days are Monday to Friday.
Please make sure that the material contains the tumor site before submitting it. Since this test method is more susceptible to contamination, please handle the specimens with care when collecting them.
When requesting this test, please be sure to also request the nucleic acid extraction item (item code No.0M961 2).
●Notes
After collecting the specimen, please process it immediately. Please note that if the number of cells in the submitted specimen is low, the test may not be possible.
CONTAINER
ARR 旧容器記号 r A
滅菌ポリスピッツ
貯蔵方法:室温
supplementary information
対象遺伝子変異等と関連する医薬品および適応がん腫
遺伝子変異等 | がん腫 | 関連する医薬品 |
---|---|---|
BRAF V600E変異 | 非小細胞肺癌 | ダブラフェニブメシル酸塩及びトラメチニブジメチルスルホキシド付加物の併用投与 |
EGFR遺伝子変異 | ゲフィチニブ、エルロチニブ塩酸塩、アファチニブマレイン酸塩、オシメルチニブメシル酸塩 | |
ALK融合遺伝子 | クリゾチニブ、アレクチニブ塩酸塩、ブリグチニブ | |
ROS1融合遺伝子 | クリゾチニブ、エヌトレクチニブ | |
MET ex14スキッピング変異 | テポチニブ塩酸塩水和物 | |
KRAS G12C遺伝子変異 | ソトラシブ | |
RET融合遺伝子 | セルペルカチニブ |